MO - NYSE

Altria Group, Inc.

MO·NYSE

$70.40

+1.7%

Consumer DefensiveTobacco

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$117.56B

EPS4.1100

P/E Ratio17.13

Earnings Date07/30/2026

35.02B

Assets

3Y-5.0%

5Y-26.0%

10Y-24.0%

38.47B

Total Liabilities

3Y-6.0%

5Y-14.0%

10Y+16.0%

-3.45B

Total Equity

58%

3Y-12.0%

5Y-218.0%

10Y-127.0%

Altria Group, Inc. Funding & Solvency Profile

MO · NYSE

Current Assets

Cash & Cash Equivalents4.48B

Net Receivables263.00M

Inventory1.07B

Other Current Assets-270.00M

Total Current Assets6 B

Non-Current Assets

Property, Plant & Equipment1.71B

Goodwill & Intangible Assets17.66B

Long-Term Investments8.63B

Other Non-Current Assets-11.00M

Total Non-Current Assets10 B

Total Assets

35.02B

Financial Health Analysis

Current Ratio

0.61x

Warning: Liquidity concerns. Current assets may not be sufficient to cover short-term obligations.

Working Capital

-3610000000

Negative working capital indicates short-term liabilities exceed short-term assets—potential liquidity stress.

Asset Composition

16% Current

Capital-intensive business with significant long-term investments in property, equipment, or intangibles.

Altria Group, Inc. Balance Sheet

MO • NYSE

Altria Group, Inc. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017	Dec 2016	Dec 2015	Dec 2014	Dec 2013	Dec 2012	Dec 2011	Dec 2010	Dec 2009	Dec 2008	Dec 2007	Dec 2006
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	4.5B	3.1B	3.7B	4B	4.5B	4.9B	2.1B	1.3B	1.3B	4.6B	2.4B	3.3B	3.2B	2.9B	3.3B	2.3B	1.9B	7.9B	4.8B	4.8B
Cash & Short-Term Investments	4.5B	3.1B	3.7B	4B	4.5B	4.9B	2.1B	1.3B	1.3B	4.6B	2.4B	3.3B	3.2B	2.9B	3.3B	2.3B	1.9B	7.9B	4.8B	4.8B
Net Receivables	263M	270M	567M	1.9B	47M	137M	152M	309M	603M	420M	124M	124M	115M	193M	268M	85M	96M	44M	83M	2.8B
Accounts Receivables	263M	177M	71M	1.7B	0.0	137M	152M	142M	142M	151M	124M	124M	115M	193M	268M	85M	96M	44M	83M	2.8B
Other Receivables	0.0	93M	496M	151M	47M	0.0	0.0	167M	461M	269M	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Inventory	1.1B	1.1B	1.2B	1.2B	1.2B	2B	2.3B	2.3B	2.2B	2.1B	2B	2B	1.9B	1.7B	1.8B	1.8B	1.8B	1.1B	10.6B	12.2B
Other Current Assets	-270M	36M	117M	138M	298M	69M	262M	326M	263M	220M	387M	1.4B	1.4B	1.5B	1.6B	1.8B	2B	2B	16.7B	9.9B
Total Current Assets	5.5B	4.5B	5.6B	7.2B	6.1B	7.1B	4.8B	4.3B	4.3B	7.3B	6.1B	6.9B	6.6B	6.3B	7.1B	6B	5.8B	11.1B	22.9B	26.2B
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	1.7B	1.6B	1.7B	1.6B	1.6B	2B	2B	1.9B	1.9B	2B	2B	2B	2B	2.1B	2.2B	2.4B	2.7B	2.2B	8.9B	17.3B
Goodwill	5.8B	6.9B	6.8B	5.2B	5.2B	5.2B	5.2B	5.2B	5.3B	5.3B	5.3B	5.3B	5.2B	5.2B	5.2B	5.2B	5.2B	77M	8B	33.2B
Intangible Assets	11.9B	13B	13.7B	12.4B	12.3B	12.6B	12.7B	12.3B	12.4B	12B	12B	12B	12.1B	12.1B	12.1B	12.1B	12.1B	3B	5B	12.1B
Goodwill & Intangible Assets	17.7B	19.9B	20.5B	17.6B	17.5B	17.8B	17.9B	17.5B	17.7B	17.3B	17.3B	17.3B	17.2B	17.3B	17.3B	17.3B	17.3B	3.1B	13B	45.3B
Long-Term Investments	8.6B	8.2B	10B	9.6B	13.5B	19.5B	23.6B	30.5B	18.9B	18.9B	6.7B	7.8B	8.5B	6.6B	5.5B	9.9B	5B	9.7B	0.0	0.0
Tax Assets	0.0	0.0	0.0	0.0	0.0	0.0	5.1B	5.2B	5.2B	8.4B	5.7B	6.1B	6.9B	5B	0.0	0.0	0.0	0.0	0.0	0.0
Other Non-Current Assets	-11M	934M	845M	965M	923M	964M	-4.1B	-3.7B	-4B	513M	-5.2B	483M	557M	3B	1.1B	1.9B	5.9B	1.1B	2B	5B
Total Non-Current Assets	28B	30.7B	33B	29.7B	33.4B	40.3B	44.4B	51.3B	38.9B	38.7B	26.4B	27.6B	28.3B	29B	29.8B	31.4B	30.9B	16.1B	34.3B	78.1B
Other Assets	1.5B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Total Assets	35B	35.2B	38.6B	37B	39.5B	47.4B	49.3B	55.6B	43.2B	45.9B	32.5B	34.5B	34.9B	35.3B	37B	37.4B	36.7B	27.2B	57.2B	104.3B
LIABILITIES
CURRENT LIABILITIES
Total Payables	750M	700M	582M	552M	449M	380M	325M	399M	374M	425M	400M	416M	409M	1.3B	1.3B	1.6B	1.5B	1.2B	2.7B	1.4B
Accounts Payable	750M	700M	582M	552M	449M	380M	325M	399M	374M	425M	400M	416M	409M	451M	503M	529M	494M	510M	611M	1.4B
Other Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	888M	841M	1B	1B	665M	2.1B	0.0
Accrued Expenses	0.0	4.8B	5.2B	4.8B	5.4B	5.6B	5.3B	5.4B	4.3B	5.8B	5.6B	5.2B	5.2B	5.5B	5.5B	5.1B	5.5B	5.8B	756M	19.4B
Short Term Debt	1.6B	1.5B	1.1B	1.6B	1.1B	1.5B	1B	13.8B	864M	0.0	4M	1B	525M	1.5B	600M	0.0	775M	135M	3.1B	4.2B
Tax Payables	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	220M	231M	318M	98M	0.0	0.0
Deferred Revenue	0.0	0.0	2.7B	2.7B	2.9B	3.2B	3B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12B	0.0
Other Current Liabilities	6.8B	1.7B	1.7B	-1B	-1.3B	-1.6B	-1.5B	1.5B	1.3B	1.2B	1.1B	1B	959M	-8M	0.0	232M	239M	0.0	239M	419M
Total Current Liabilities	9.2B	8.8B	11.3B	8.6B	8.6B	9.1B	8.2B	21.2B	6.8B	7.4B	7.1B	7.7B	7.1B	8.3B	7.6B	6.8B	8B	7.1B	18.8B	25.4B
NON-CURRENT LIABILITIES
Long Term Debt	24.1B	23.4B	25.1B	25.1B	26.9B	28B	27B	11.9B	13B	13.9B	12.8B	13.7B	14B	12.4B	13.1B	12.2B	11.2B	7.3B	8B	14.5B
Deferred Revenue (Non-Current)	0.0	0.0	0.0	2.7B	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4B	3.6B	3.5B	3.6B	0.0	0.0
Deferred Tax Liabilities (Non-Current)	3.4B	3.7B	2.8B	2.9B	3.7B	4.5B	5.1B	5.2B	5.2B	8.4B	5.7B	6.1B	6.9B	5B	7.6B	4.6B	8.6B	5B	7.1B	10.9B
Other Non-Current Liabilities	1.8B	1.4B	2.8B	1.5B	1.9B	2.9B	2.6B	2.6B	2.7B	3.4B	4B	4B	2.8B	4.8B	932M	4.9B	1.4B	1.3B	4.8B	10.3B
Total Non-Current Liabilities	29.3B	28.6B	30.7B	32.3B	32.6B	35.4B	34.8B	19.7B	21B	25.8B	22.6B	23.8B	23.7B	23.9B	25.6B	25.3B	24.6B	17.2B	19.9B	35.7B
Total Liabilities	38.5B	37.4B	42.1B	40.9B	41.1B	44.5B	43B	40.8B	27.8B	33.2B	29.7B	31.5B	30.7B	32.2B	33.2B	32.2B	32.6B	24.4B	38.7B	61.1B
SHAREHOLDERS' EQUITY
Treasury Stock	-43.2B	-42.2B	-38.8B	-37.8B	-36B	-34.3B	-34.4B	-33.5B	-31.9B	-28.9B	-27.8B	-27.3B	-26.3B	-25.7B	-24.6B	-23.5B	-23.9B	-24.4B	-23.5B	-23.7B
Preferred Stock	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	348M	0.0
Common Stock	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M	935M
Additional Paid-In Capital	5.9B	5.9B	5.9B	5.9B	5.9B	5.9B	6B	6B	6B	5.9B	5.8B	5.7B	5.7B	5.7B	5.7B	5.8B	6B	6.4B	6.9B	6.4B
Retained Earnings	0.0	35.5B	31.1B	29.8B	30.7B	34.7B	36.5B	44B	42.3B	36.9B	27.3B	26.3B	25.2B	24.3B	23.6B	23.5B	22.6B	22.1B	34.4B	59.9B
Accumulated Other Comprehensive Income/Loss	32.8B	-2.4B	-2.7B	-2.8B	-3.1B	-4.3B	-2.9B	-2.5B	-1.9B	-2.1B	-3.3B	-2.7B	-1.4B	-2B	-1.9B	-1.5B	-1.6B	-2.2B	-237M	-3.8B
Other Total Stockholders' Equity	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	348M	0.0
Total Stockholders' Equity	-3.5B	-2.2B	-3.5B	-4B	-1.6B	2.8B	6.2B	14.8B	15.4B	12.8B	2.9B	3B	4.1B	3.1B	3.7B	5.2B	4.1B	2.8B	18.6B	39.6B
Total Equity	-3.5B	-2.2B	-3.5B	-3.9B	-1.6B	2.9B	6.3B	14.8B	15.4B	12.8B	2.9B	3B	4.1B	3.1B	3.7B	5.2B	4.1B	2.8B	18.6B	43.1B
Minority Interest	50M	50M	50M	50M	0.0	86M	97M	2M	3M	3M	-7M	-4M	-1M	2M	35M	35M	3M	0.0	0.0	3.5B
SUMMARY
Total Liabilities & Equity	35B	35.2B	38.6B	37B	39.5B	47.4B	49.3B	55.6B	43.2B	45.9B	32.5B	34.5B	34.9B	35.3B	37B	37.4B	36.7B	27.2B	57.2B	104.3B
Total Investments	8.6B	8.2B	10B	9.6B	13.5B	19.5B	23.6B	30.5B	18.9B	18.9B	6.7B	7.8B	8.5B	6.6B	5.5B	9.9B	5B	9.7B	0.0	0.0
Total Debt	25.7B	24.9B	26.2B	26.7B	28B	29.5B	28B	25.7B	13.9B	13.9B	12.9B	14.7B	14.5B	13.9B	13.7B	12.2B	12B	7.5B	11B	18.7B
Net Debt	21.2B	21.8B	22.5B	22.7B	23.5B	24.5B	25.9B	24.4B	12.6B	9.3B	10.6B	11.4B	11.3B	11B	10.4B	9.9B	10.1B	-442M	4.5B	13.7B
Shares Outstanding	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827	1,678,916,827

SEC Filings

MO - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
10-K/A 10-K/A 2025 FY (Amended) FY	May 27, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	May 18, 2026	May 13, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	April 30, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	April 30, 2026	April 30, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 02, 2026	May 14, 2026	2026	View Filing
10-K 10-K 2025 FY FY	February 25, 2026	December 31, 2025	2025	View Filing
8-K 8-K 2026 N/A	January 29, 2026	January 29, 2026	2026	View Filing
8-K 8-K 2026 N/A	January 29, 2026	January 28, 2026	2026	View Filing
8-K 8-K 2025 N/A	December 11, 2025	December 08, 2025	2025	View Filing
8-K 8-K 2025 N/A	October 30, 2025	October 29, 2025	2025	View Filing

Showing 1 to 10 of 560 filings

Related Guides

Blog Categories

Continue your MO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.